Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Agrify Corporation Announces $3.4 Million Sales Order From New Jersey Woman-Owned Business HarvestWorks Farm
-
Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
-
Progyny, Inc. Announces Share Repurchase Program
-
Vic.ai Supercharges Payments by Adding Early Payment Discounts and Zero US Transaction Fees to Leading Autonomous Finance Platform
-
Xos, Inc. Secures Purchase Order from Mission Linen Supply for New 22’ Stepvan Option
-
Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results
-
Evaxion to Host R&D Day on March 19, 2024, Highlighting its Latest Technology Innovations
-
Terranet provides update on prototype tests in lab during the first quarter
-
Codere Online Reports Financial Results for the Fourth Quarter and Full Year 2023
-
Muscular Dystrophy Association Applauds Landmark Proposal on Accessible Air Travel at The White House
-
Iceland Seafood International hf: Date of transaction 29.2.2024
-
Dimensional Fund Advisors Ltd. : Form 8.3 - Ageas SA/NV - Ordinary Shares
-
St Kitts and Nevis unveils the Investment Gateway Summit
-
2023 was a good year with acquisitions and financial results as guided
-
Xometry Reports Fourth Quarter and Full Year 2023 Results
-
Clearside Biomedical to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on Tuesday, March 12, 2024
-
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results
-
Xometry Appoints James Miln as New Chief Financial Officer
-
Hemlo Explorers Announces Receipt of Final Tranche of OJEP Grant
-
GH Research Reports Full Year 2023 Financial Results and Provides Business Updates
-
Brink's Announces Fourth-Quarter and Full-Year 2023 Results
-
NuVista Energy Ltd. Announces Record Year End 2023 Reserves, Financial and Operating Results
-
Enviri Corporation Reports Fourth Quarter And Full Year 2023 Results
-
NFI announces fourth quarter and full year 2023 results
-
Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024
-
Alta Equipment Group Announces Date of Fourth Quarter and Full Year 2023 Financial Results Release, Conference Call and Webcast
-
Chicago Atlantic Real Estate Finance Extends Maturity of its Revolving Credit Facility to June 2026 and Increases Size of the Accordion Feature to $150 Million
-
ASLAN Pharmaceuticals Receives Favorable Opinion From the European Patent Office on Composition of Matter Patent Application for Farudodstat
-
Vertex Announces Fourth Quarter and Full Year 2023 Financial Results
-
Brink's Announces Fourth-Quarter and Full-Year 2023 Results
-
95% Say They Would Recommend Sana Commerce on Gartner® Peer Insights™
-
Rivalry to Present at NEXT Summit New York 2024
-
The Tile Shop Reports Fourth Quarter and Full-Year 2023 Results
-
Milestone Pharmaceuticals Announces Pricing of $30.0 Million Public Offering of Common Shares and Pre-Funded Warrants
-
Lantronix Names Kurt Hoff as Vice President, Worldwide Sales
-
Hydrofarm Holdings Group Announces Fourth Quarter and Full Year 2023 Results
-
Lithium Ionic Extends Payment Schedule for Acquisition of the Vale and Borges Claims
-
Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update
-
EyePoint Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on March 7, 2024
-
Vantage Hemp Co. Achieves GMP Certification from Australia's Therapeutic Goods Administration
-
Arqit Awarded Top Honors in Two Categories at the Global Mobile Awards at 2024 Mobile World Congress
-
Autolus Therapeutics to Report Full Year 2023 Financial Results and Business Updates on March 14, 2024
-
ASLAN Pharmaceuticals Receives Favorable Opinion From the European Patent Office on Composition of Matter Patent Application for Farudodstat
-
Akero Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
-
Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024
-
Applied UV’s Subsidiary has Purchased the Continuing Business and a Multi-Year Exclusive Global Licensing Agreement With Element Designs
-
Stella-Jones Announces Fourth Quarter and Year-End Results
-
Advantage Solutions exceeded 2023 financial guidance with solid fourth-quarter performance and expects continued growth in 2024
-
Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
-
Vantage Hemp Co. Achieves GMP Certification from Australia's Therapeutic Goods Administration
